期刊文献+

Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer 被引量:5

Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer
下载PDF
导出
摘要 AIM: To investigate the expression and oncogenic role of nemo-like kinase(NLK) in colorectal cancer.METHODS: Expression of NLK protein was assessed by immunohistochemistry in tissue specimens from 56 cases of normal colorectal mucosa, 51 cases of colorectal adenoma, and 712 cases of colorectal cancer. In addition, NLK expression was knocked down using a lentivirus carrying NLK small hairpin RNA in colorectal cancer cells. Cell viability methylthiazoletetrazolium assays, colony formation assays, flow cytometry cell cycle assays, Transwell migration assays, and gene expression assays were performed to explore its role on proliferation and migration of colorectal cancer.RESULTS: Expression of NLK protein progressively increased in tissues from the normal mucosa through adenoma to various stages of colorectal cancer. Overexpression of NLK protein was associated with advanced tumor-lymph node-metastasis stages, poor differentiation, lymph node and distant metastases, and a higher recurrence rate of colorectal cancer(P < 0.05). Multivariate analyses showed that NLK expression was an independent prognostic factor to predict overallsurvival(hazard ratio 2.57, 95% confidence interval: 1.66-3.98; P < 0.001) and disease-free survival(hazard ratio 1.96, 95% confidence interval: 1.40-2.74: P < 0.001) of colorectal cancer patients. Furthermore, knockdown of NLK expression in colorectal cancer cell lines reduced cell viability, colony formation, and migration, and arrested tumor cells at the G0/G1 phase of the cell cycle. At the gene level, knockdown of NLK expression inhibited matrix metalloproteinase-2 expression in colorectal cancer cells. CONCLUSION: NLK overexpression is an independent prognostic factor in colorectal cancer and knockdown of NLK expression inhibits colorectal cancer progression and metastasis. AIM: To investigate the expression and oncogenic role of nemo-like kinase(NLK) in colorectal cancer.METHODS: Expression of NLK protein was assessed by immunohistochemistry in tissue specimens from 56 cases of normal colorectal mucosa, 51 cases of colorectal adenoma, and 712 cases of colorectal cancer. In addition, NLK expression was knocked down using a lentivirus carrying NLK small hairpin RNA in colorectal cancer cells. Cell viability methylthiazoletetrazolium assays, colony formation assays, flow cytometry cell cycle assays, Transwell migration assays, and gene expression assays were performed to explore its role on proliferation and migration of colorectal cancer.RESULTS: Expression of NLK protein progressively increased in tissues from the normal mucosa through adenoma to various stages of colorectal cancer. Overexpression of NLK protein was associated with advanced tumor-lymph node-metastasis stages, poor differentiation, lymph node and distant metastases, and a higher recurrence rate of colorectal cancer(P < 0.05). Multivariate analyses showed that NLK expression was an independent prognostic factor to predict overallsurvival(hazard ratio 2.57, 95% confidence interval: 1.66-3.98; P < 0.001) and disease-free survival(hazard ratio 1.96, 95% confidence interval: 1.40-2.74: P < 0.001) of colorectal cancer patients. Furthermore, knockdown of NLK expression in colorectal cancer cell lines reduced cell viability, colony formation, and migration, and arrested tumor cells at the G0/G1 phase of the cell cycle. At the gene level, knockdown of NLK expression inhibited matrix metalloproteinase-2 expression in colorectal cancer cells. CONCLUSION: NLK overexpression is an independent prognostic factor in colorectal cancer and knockdown of NLK expression inhibits colorectal cancer progression and metastasis.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第29期8836-8847,共12页 世界胃肠病学杂志(英文版)
基金 Supported by National Natural Science Foundation of China,No.81272670,No.81201936 and No.81025015
关键词 COLORECTAL cancer Gene regulation Nemolikekinase PROGNOSIS Colorectal cancer Gene regulation Nemolike kinase Prognosis
  • 相关文献

参考文献32

  • 1Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D.Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID:21296855 DOI: 10.3322/caac.20107].
  • 2Ou J, Peng Y, Deng J, Miao H, Zhou J, Zha L, Zhou R, Yu L, ShiH, Liang H. Endothelial cell-derived fibronectin extra domainA promotes colorectal cancer metastasis via inducing epithelialmesenchymaltransition. Carcinogenesis 2014; 35: 1661-1670[PMID: 24743511 DOI: 10.1093/carcin/bgu090].
  • 3Lonnroth C, Andersson M, Asting AG, Nordgren S, Lundholm K.Preoperative low dose NSAID treatment influences the genes forstemness, growth, invasion and metastasis in colorectal cancer. IntJ Oncol 2014; 45: 2208-2220 [PMID: 25340937 DOI: 10.3892/ijo.2014.2686].
  • 4Gao XH, Yu ZQ, Zhang C, Bai CG, Zheng JM, Fu CG. DNAtopoisomerase II alpha: a favorable prognostic factor in colorectalcaner. Int J Colorectal Dis 2012; 27: 429-435 [PMID: 22076611DOI: 10.1007/s00384-011-1346-x].
  • 5Glockzin G, Gerken M, Lang SA, Klinkhammer-Schalke M, Piso P,Schlitt HJ. Oxaliplatin-based versus irinotecan-based hyperthermicintraperitoneal chemotherapy (HIPEC) in patients with peritonealmetastasis from appendiceal and colorectal cancer: a retrospectiveanalysis. BMC Cancer 2014; 14: 807 [PMID: 25369730 DOI: 10.1186/1471-2407-14-807].
  • 6Nakanishi M, Kuriu Y, Murayama Y, Konishi H, Komatsu S,Shiozaki A, Ikoma H, Kubota T, Ichikawa D, Fujiwara H, OkamotoK, Sakakura C, Otsuji E. Efficacy of perioperative chemotherapyin patients with colorectal cancer undergoing hepatectomy forresectable synchronous liver metastasis. Hepatogastroenterology2014; 61: 1582-1587 [PMID: 25436346].
  • 7Ji K, Ye L, Ruge F, Hargest R, Mason MD, Jiang WG. Implicationof metastasis suppressor gene, Kiss-1 and its receptor Kiss-1R incolorectal cancer. BMC Cancer 2014; 14: 723 [PMID: 25260785DOI: 10.1186/1471-2407-14-723].
  • 8Ahmed IA, Kelly SB, Anderson JJ, Angus B, Challen C, Lunec J.The predictive value of p53 and p33(ING1b) in patients with Dukes C colorectal cancer. Colorectal Dis 2008; 10: 344-351 [PMID:17949449 DOI: 10.1111/j.1463-1318.2007.01317.x].
  • 9Ishihara S, Hayama T, Yamada H, Nozawa K, Matsuda K, Miyata H,Yoneyama S, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, NozawaH, Kanazawa T, Kazama S, Yamaguchi H, Sunami E, Kitayama J,Hashiguchi Y, Sugihara K, Watanabe T. Prognostic impact of primarytumor resection and lymph node dissection in stage IV colorectalcancer with unresectable metastasis: a propensity score analysisin a multicenter retrospective study. Ann Surg Oncol 2014; 21:2949-2955 [PMID: 24763981 DOI: 10.1245/s10434-014-3719-1].
  • 10Lou X, Kang B, Zhang J, Hao C, Tian X, Li W, Xu N, Lu Y, Liu S.MFAP3L activation promotes colorectal cancer cell invasion andmetastasis. Biochim Biophys Acta 2014; 1842: 1423-1432 [PMID:24735981 DOI: 10.1016/j.bbadis.2014.04.006].

同被引文献12

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部